The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Rex C. Haydon and Hue H. Luu.
Connection Strength

4.249
  1. Transition to resistance: An unexpected role of the EMT in cancer chemoresistance. Genes Dis. 2016 Mar; 3(1):3-6.
    View in: PubMed
    Score: 0.140
  2. Opening the LOX to bone metastasis: The role of secreted lysyl oxidase in skeletal recurrence of breast cancers. Genes Dis. 2015 Dec; 2(4):288-290.
    View in: PubMed
    Score: 0.137
  3. IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. Cancer Lett. 2013 Aug 09; 336(1):222-30.
    View in: PubMed
    Score: 0.116
  4. The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev. 2013 Feb; 9(1):55-77.
    View in: PubMed
    Score: 0.114
  5. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res. 2010 Apr 15; 16(8):2235-45.
    View in: PubMed
    Score: 0.094
  6. Therapeutic Implications of PPARgamma in Human Osteosarcoma. PPAR Res. 2010; 2010:956427.
    View in: PubMed
    Score: 0.093
  7. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis. 2009; 26(7):599-610.
    View in: PubMed
    Score: 0.088
  8. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007 May; 25(5):665-77.
    View in: PubMed
    Score: 0.077
  9. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res. 2007 Jan; 454:237-46.
    View in: PubMed
    Score: 0.075
  10. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 2005 Nov 08; 229(1):135-48.
    View in: PubMed
    Score: 0.069
  11. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 2005; 22(4):319-29.
    View in: PubMed
    Score: 0.065
  12. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004 Dec; 4(8):653-71.
    View in: PubMed
    Score: 0.065
  13. Long non-coding RNA (LncRNA) HOTAIR regulates BMP9-induced osteogenic differentiation by targeting the proliferation of mesenchymal stem cells (MSCs). Aging (Albany NY). 2021 01 10; 13(3):4199-4214.
    View in: PubMed
    Score: 0.049
  14. The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition. Am J Transl Res. 2020; 12(12):8084-8098.
    View in: PubMed
    Score: 0.049
  15. Blockade of IGF/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma. Am J Cancer Res. 2020; 10(10):3248-3266.
    View in: PubMed
    Score: 0.048
  16. A reverse transcriptase-mediated ribosomal RNA depletion (RTR2D) strategy for the cost-effective construction of RNA sequencing libraries. J Adv Res. 2020 Jul; 24:239-250.
    View in: PubMed
    Score: 0.046
  17. lncRNA Rmst acts as an important mediator of BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) by antagonizing Notch-targeting microRNAs. Aging (Albany NY). 2019 12 11; 11(24):12476-12496.
    View in: PubMed
    Score: 0.046
  18. Highly expressed BMP9/GDF2 in postnatal mouse liver and lungs may account for its pleiotropic effects on stem cell differentiation, angiogenesis, tumor growth and metabolism. Genes Dis. 2020 Jun; 7(2):235-244.
    View in: PubMed
    Score: 0.045
  19. Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells. ACS Synth Biol. 2019 09 20; 8(9):2092-2105.
    View in: PubMed
    Score: 0.045
  20. The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine. Genes Dis. 2019 Sep; 6(3):201-223.
    View in: PubMed
    Score: 0.045
  21. A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells. Cancer Gene Ther. 2020 06; 27(6):424-437.
    View in: PubMed
    Score: 0.044
  22. Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs). Genes Dis. 2019 Sep; 6(3):258-275.
    View in: PubMed
    Score: 0.044
  23. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep. 2018 12 17; 8(1):17914.
    View in: PubMed
    Score: 0.043
  24. Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation. J Cell Biochem. 2018 11; 119(11):8872-8886.
    View in: PubMed
    Score: 0.042
  25. A blockade of PI3K? signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model. Sci Rep. 2018 Jul 20; 8(1):10988.
    View in: PubMed
    Score: 0.042
  26. Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells. Cell Physiol Biochem. 2018; 47(3):957-971.
    View in: PubMed
    Score: 0.041
  27. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018 Jun; 5(2):77-106.
    View in: PubMed
    Score: 0.041
  28. Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference. Genes Dis. 2018 Jun; 5(2):172-184.
    View in: PubMed
    Score: 0.041
  29. Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs). Genes Dis. 2018 Jun; 5(2):137-149.
    View in: PubMed
    Score: 0.041
  30. The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis. 2018 Mar; 5(1):62-74.
    View in: PubMed
    Score: 0.040
  31. CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs). Oncotarget. 2017 Dec 19; 8(67):111847-111865.
    View in: PubMed
    Score: 0.040
  32. lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling. Oncotarget. 2017 Jun 27.
    View in: PubMed
    Score: 0.039
  33. lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling. Oncotarget. 2017 Aug 08; 8(32):53581-53601.
    View in: PubMed
    Score: 0.039
  34. Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors. Oncotarget. 2017 Apr 18; 8(16):27105-27119.
    View in: PubMed
    Score: 0.038
  35. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). Oncotarget. 2017 Feb 21; 8(8):12968-12982.
    View in: PubMed
    Score: 0.038
  36. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma. Histopathology. 2017 Apr; 70(5):734-745.
    View in: PubMed
    Score: 0.038
  37. A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities. Cell Physiol Biochem. 2016; 39(3):871-88.
    View in: PubMed
    Score: 0.036
  38. An NgAgo tool for genome editing: did CRISPR/Cas9 just find a competitor? Genes Dis. 2016 Sep; 3(3):169-170.
    View in: PubMed
    Score: 0.036
  39. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation. Cell Physiol Biochem. 2015; 37(6):2375-92.
    View in: PubMed
    Score: 0.035
  40. Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells. Sci Rep. 2015 Dec 07; 5:17523.
    View in: PubMed
    Score: 0.035
  41. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest. 2016 Feb; 96(2):116-36.
    View in: PubMed
    Score: 0.035
  42. Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis. 2015 Dec; 2(4):307-327.
    View in: PubMed
    Score: 0.035
  43. Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries. Genes Dis. 2015 Dec; 2(4):295-298.
    View in: PubMed
    Score: 0.034
  44. Molecular pathogenesis and therapeutic strategies of human osteosarcoma. J Biomed Res. 2015 Aug 30; 30.
    View in: PubMed
    Score: 0.034
  45. TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR. PLoS One. 2015; 10(7):e0132666.
    View in: PubMed
    Score: 0.034
  46. Insider information: Testing cancer drug sensitivity for personalized therapy. Genes Dis. 2015 Sep; 2(3):219-221.
    View in: PubMed
    Score: 0.034
  47. Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system. Genes Dis. 2015 Mar; 2(1):96-105.
    View in: PubMed
    Score: 0.033
  48. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. Curr Cancer Drug Targets. 2015; 15(8):726-38.
    View in: PubMed
    Score: 0.033
  49. Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials. 2015 Jan; 39:145-54.
    View in: PubMed
    Score: 0.032
  50. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly. PLoS One. 2014; 9(11):e113064.
    View in: PubMed
    Score: 0.032
  51. Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver. Cell Physiol Biochem. 2014; 34(4):1318-38.
    View in: PubMed
    Score: 0.032
  52. Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncol Rep. 2014 Sep; 32(3):1013-20.
    View in: PubMed
    Score: 0.031
  53. The piggyBac transposon-mediated expression of SV40 T antigen efficiently immortalizes mouse embryonic fibroblasts (MEFs). PLoS One. 2014; 9(5):e97316.
    View in: PubMed
    Score: 0.031
  54. Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term Proliferative Capability While Retaining Chondrogenic Phenotype. Cell Transplant. 2015; 24(6):1053-66.
    View in: PubMed
    Score: 0.031
  55. Overexpression of Ad5 precursor terminal protein accelerates recombinant adenovirus packaging and amplification in HEK-293 packaging cells. Gene Ther. 2014 Jul; 21(7):629-37.
    View in: PubMed
    Score: 0.031
  56. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs). PLoS One. 2014; 9(4):e94397.
    View in: PubMed
    Score: 0.031
  57. Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids. PLoS One. 2014; 9(4):e93608.
    View in: PubMed
    Score: 0.031
  58. Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. Stem Cells Dev. 2014 Jun 15; 23(12):1405-16.
    View in: PubMed
    Score: 0.031
  59. Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS One. 2014; 9(3):e92908.
    View in: PubMed
    Score: 0.031
  60. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling. Curr Cancer Drug Targets. 2014; 14(3):274-85.
    View in: PubMed
    Score: 0.030
  61. Crosstalk between Wnt/ß-catenin and estrogen receptor signaling synergistically promotes osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2013; 8(12):e82436.
    View in: PubMed
    Score: 0.030
  62. Modulation of ß-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Int J Med Sci. 2013; 10(13):1888-98.
    View in: PubMed
    Score: 0.030
  63. Destabilization of heterologous proteins mediated by the GSK3ß phosphorylation domain of the ß-catenin protein. Cell Physiol Biochem. 2013; 32(5):1187-99.
    View in: PubMed
    Score: 0.030
  64. The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem. 2013; 32(4):1083-96.
    View in: PubMed
    Score: 0.030
  65. Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A. 2014 Oct; 102(10):3429-38.
    View in: PubMed
    Score: 0.030
  66. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells. PLoS One. 2013; 8(9):e73086.
    View in: PubMed
    Score: 0.030
  67. Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cell Physiol Biochem. 2013; 32(2):486-98.
    View in: PubMed
    Score: 0.030
  68. BMP signaling in mesenchymal stem cell differentiation and bone formation. J Biomed Sci Eng. 2013 Aug; 6(8A):32-52.
    View in: PubMed
    Score: 0.030
  69. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res. 2013 Nov; 31(11):1796-803.
    View in: PubMed
    Score: 0.029
  70. Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med. 2013 Sep; 17(9):1160-72.
    View in: PubMed
    Score: 0.029
  71. Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. Int J Med Sci. 2013; 10(8):1035-46.
    View in: PubMed
    Score: 0.029
  72. Decellularized liver scaffolds effectively support the proliferation and differentiation of mouse fetal hepatic progenitors. J Biomed Mater Res A. 2014 Apr; 102(4):1017-25.
    View in: PubMed
    Score: 0.029
  73. Characterization of chondrocyte scaffold carriers for cell-based gene therapy in articular cartilage repair. J Biomed Mater Res A. 2013 Dec; 101(12):3542-50.
    View in: PubMed
    Score: 0.029
  74. BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells. 2013; 2(1):1-21.
    View in: PubMed
    Score: 0.029
  75. Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis. 2013 Feb; 5(1):13-31.
    View in: PubMed
    Score: 0.029
  76. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci. 2013 Jan 15; 126(Pt 2):532-41.
    View in: PubMed
    Score: 0.028
  77. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Miner Res. 2012 Jul; 27(7):1566-75.
    View in: PubMed
    Score: 0.027
  78. Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential. J Invest Dermatol. 2012 Oct; 132(10):2479-2483.
    View in: PubMed
    Score: 0.027
  79. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One. 2012; 7(2):e32428.
    View in: PubMed
    Score: 0.027
  80. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int. 2011; 2011:201371.
    View in: PubMed
    Score: 0.026
  81. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr Gene Ther. 2011 Jun; 11(3):229-40.
    View in: PubMed
    Score: 0.025
  82. Defective osteogenic differentiation in the development of osteosarcoma. Sarcoma. 2011; 2011:325238.
    View in: PubMed
    Score: 0.025
  83. The therapeutic potential of the Wnt signaling pathway in bone disorders. Curr Mol Pharmacol. 2011 Jan; 4(1):14-25.
    View in: PubMed
    Score: 0.025
  84. Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Stem Cells Int. 2010 Dec 16; 2010:519028.
    View in: PubMed
    Score: 0.025
  85. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling. Int J Oncol. 2011 Feb; 38(2):437-45.
    View in: PubMed
    Score: 0.025
  86. Lysophosphatidic acid acyltransferase ß (LPAATß) promotes the tumor growth of human osteosarcoma. PLoS One. 2010 Dec 01; 5(12):e14182.
    View in: PubMed
    Score: 0.025
  87. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010 Nov; 25(11):2447-59.
    View in: PubMed
    Score: 0.024
  88. Tetrandrine inhibits Wnt/ß-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol. 2011 Feb; 79(2):211-9.
    View in: PubMed
    Score: 0.024
  89. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells. 2010 Aug 26; 2(4):67-80.
    View in: PubMed
    Score: 0.024
  90. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010 Jul 30; 5(7):e11917.
    View in: PubMed
    Score: 0.024
  91. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem. 2010 Sep 17; 285(38):29588-98.
    View in: PubMed
    Score: 0.024
  92. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010 06; 25(6):795-806.
    View in: PubMed
    Score: 0.024
  93. Molecular basis of differentiation therapy for soft tissue sarcomas. Trends Cancer Res. 2010; 6:69-90.
    View in: PubMed
    Score: 0.023
  94. Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int. 2009 Nov; 29(10):1569-81.
    View in: PubMed
    Score: 0.023
  95. Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem. 2009 Sep 01; 108(1):295-303.
    View in: PubMed
    Score: 0.022
  96. Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1147-53.
    View in: PubMed
    Score: 0.022
  97. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation. 2009 Nov; 78(4):195-204.
    View in: PubMed
    Score: 0.022
  98. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009 May; 18(4):545-59.
    View in: PubMed
    Score: 0.022
  99. Hey1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem. 2009 Jan 02; 284(1):649-659.
    View in: PubMed
    Score: 0.021
  100. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med. 2009 Aug; 13(8B):2448-2464.
    View in: PubMed
    Score: 0.021
  101. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008 Dec; 88(12):1264-77.
    View in: PubMed
    Score: 0.021
  102. Regulation of osteogenic differentiation during skeletal development. Front Biosci. 2008 Jan 01; 13:2001-21.
    View in: PubMed
    Score: 0.020
  103. BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am. 2007 Jun; 89(6):1315-20.
    View in: PubMed
    Score: 0.019
  104. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene. 2007 Jun 15; 395(1-2):160-9.
    View in: PubMed
    Score: 0.019
  105. Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest. 2007 Feb; 87(2):97-103.
    View in: PubMed
    Score: 0.019
  106. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007; 2(5):1236-47.
    View in: PubMed
    Score: 0.019
  107. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006 Apr; 26(8):2955-64.
    View in: PubMed
    Score: 0.018
  108. Gene therapy for bone regeneration. Curr Gene Ther. 2005 Apr; 5(2):167-79.
    View in: PubMed
    Score: 0.017
  109. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Dec 31; 279(53):55958-68.
    View in: PubMed
    Score: 0.016
  110. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004 Sep; 11(17):1312-20.
    View in: PubMed
    Score: 0.016
  111. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Jul 30; 279(31):32941-9.
    View in: PubMed
    Score: 0.016
  112. Dual regulation of gene expression mediated by tetracycline and Cre recombinase. Biotechniques. 2004 Mar; 36(3):390-2, 394, 396.
    View in: PubMed
    Score: 0.015
  113. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem. 2003 Dec 15; 90(6):1149-65.
    View in: PubMed
    Score: 0.015
  114. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003 Aug; 85(8):1544-52.
    View in: PubMed
    Score: 0.015
  115. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.